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Abstract
Background: Papillary carcinoma is the most common differentiated malignant thyroid neoplasm.
The biological course of this cancer is typically indolent with a protracted clinical course.
Metastases commonly occur in regional lymph nodes, and distant metastasis is a late and rare
occurrence. We report a patient who presented with cerebellar metastasis prior to the diagnosis
of papillary thyroid carcinoma and review the literature of brain metastasis from papillary thyroid
carcinoma.
Results: A 75-year old female presented at the emergency room with progressive dizziness,
headache and vomiting, where a brain CT and MRI showed a posterior cerebellar tumor. Surgical
resection revealed papillary carcinoma consistent with thyroid origin. Subsequent ultrasound and
CT-scan revealed a thyroid nodule, after which the patient underwent total thyroidectomy.
Pathologic evaluation was consistent with papillary thyroid carcinoma.
Conclusion: Brain metastasis may rarely be the initial presentation of papillary thyroid carcinoma.
Solitary brain metastasis can completely be resected with better prognosis.
Introduction
Papillary thyroid carcinoma (PTC) is the most common
thyroid cancer, representing approximately 80% to 90%
of all newly diagnosed thyroid cancers [1]. PTC is typically
characterized by an indolent clinical course in compari-
son to other differentiated and undifferentiated thyroid
malignancies [2,3]. Radiation is the best known risk factor
for PTC [2].
PTC commonly metastasizes to lymph nodes but [1] dis-
tant metastases at time of presentation may rarely occur
and account for 9% to 10% during the course of follow-
up [2]. The presence of distant metastases is a grave event
associated with decreased survival rates of 37% and 24%
at 5 and 10 years respectively [4]. Brain metastasis from a
thyroid primary is extremely rare with approximately 23
reported instances [5-14].
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We reported a patient who presented initially with cere-
bellar metastasis from an undiagnosed primary PTC and
review reported instances of PTC with brain metastasis.
Case presentation
A 75-year old female presented at the emergency room
with dizziness, headache and vomiting for five days. Phys-
ical examination was unremarkable except for hoarseness
of voice of one-year duration, which was investigated with
negative physical findings.
She was referred to the neurological service where a com-
puterized tomography (CT) of the brain showed a left
posterior fossa mass of high density, causing compression
on the basal cistern and obstructive hydrocephalus. Brain
Magnetic Resonance Imaging (MRI) showed a hemor-
rhagic mass lesion involving the medial aspect of the left
cerebellum (Figure 1).
The patient underwent a left occipital craniotomy and
excision of the cerebellar tumor that showed metastasis
consistent with thyroid primary.
A subsequent thorough neck examination revealed a fairly
palpable right thyroid lobe nodule and small right-neck
lymph nodes. A neck ultrasound (US) confirmed the pres-
ence of an ill-defined nodule located posteriorly in the
right thyroid lobe. A follow-up neck CT with contrast (Fig-
ure 2) showed enlarged homogeneous thyroid gland with
multiple calcifications; only one calcified lymph node
could be identified in the right jugulodigastric chain. A
US-guided fine needle aspiration from the right lobe was
performed and rendered a diagnosis suggestive of papil-
lary thyroid carcinoma. The patient underwent total thy-
roidectomy, during which an involvement of the right
recurrent laryngeal nerve was noted and right lymph
nodes neck dissection. The postoperative course was une-
ventful, and the patient was treated with radioiodine.
Pathology
Brain Resection
Gross findings
Brain specimen consisted of fragments of friable light tan
and soft tumor tissue admixed with brain tissue.
Histopathology
Tumor showed papillary fronds with fibrovascular core
lined by columnar-to-cuboidal tumor cells, with occa-
sional nuclear inclusion and grooving and abundant cyto-
plasms consistent with metastatic papillary thyroid
carcinoma (Figure 3).
Brain MRI showed hemorrhagic mass involving the medial  aspect of the left cerebellum and crossing the midline to the  right hemisphere Figure 1
Brain MRI showed hemorrhagic mass involving the 
medial aspect of the left cerebellum and crossing the 
midline to the right hemisphere.
A neck CT scan with contrast of the patient showing a right  thyroid lesion Figure 2
A neck CT scan with contrast of the patient showing 
a right thyroid lesion.
Photomicrograph of the brain metastasis showing papillary  carcinoma consistent with thyroid primary Figure 3
Photomicrograph of the brain metastasis showing 
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Fine Needle Aspiration
The aspirated materials comprised of individual cells and
cluster of tumor with fibro-vascular core. The tumor cells
exhibited nuclear grooving and intracellular inclusion
bodies consistent with papillary thyroid carcinoma.
Thyroid Resection
Gross findings
Gross examination of the thyroid revealed a well-circum-
scribed, light-tan and friable 2.5-cm nodule in the right
lobe.
Histopathology
The tumor manifested papillary formation lined by
columnar cells with clear and oncocytic cytoplasmic fea-
tures and nuclear characteristics consistent with papillary
thyroid carcinoma, tall cell variant. Of the 13 lymph
nodes dissected, only one was positive for papillary carci-
noma (Figure 4). The thyroid tumor showed identical fea-
tures with the brain lesion.
Immunohistochemically
The tumor cells reacted to epithelial membrane antigen,
cytokeratin, thyroid transcription factor (TTF1) (Figure 5)
and focally to thyroglobulin antibodies.
Discussion
We present, to our knowledge, the first instance of cerebel-
lar metastasis of papillary thyroid carcinoma prior to the
identification of primary thyroid papillary carcinoma.
Prior cases of brain metastasis from occult carcinoma
measuring (< 3 mm) were recently published [12,13]. In
this report, the patient presented with neurological symp-
toms initially, but the thyroid primary was identified at
the time [12,13]. In both of these reports, the site of the
metastasis was the occipital lobes. Brain metastases are
rare (0.15 – 1.3% of all metastatic thyroid carcinoma) [4].
Although several brain metastasis have been reported,
(Additional file 1) the primary thyroid carcinoma was
diagnosed at the time of the brain metastasis [5-
11,14,15].
The most common sites for distant metastasis of PTC are
the lungs, followed by the bone [3], and rarely to the skin,
liver and brain [2-17]. The literature review showed a
reported case of metastasis to each of the following sites:
breast, parotid, adrenal, pituitary, kidney, porta hepatis,
the orbit, the sphenoid sinus, pancreas and the skeletal
muscles.
Several investigators have attempted to determine the risk
factors for distant metastases which include male gender,
advanced age, histologic grade, extrathyroidal invasion at
initial examination, and completeness of surgical resec-
tion of the primary tumor [1,16].
Chiu A C et al, [18] reported 47 instances of brain metas-
tases from thyroid cancer (32 of them with differentiated
carcinoma), that were presented at M.D Anderson Cancer
Center between March 1944 through September 1995. In
that study, 68% were identified during the subsequent
course of disease, 23% discovered at autopsy, and only
15% as a primary clinical feature at initial presentation.
The median survival was 4.7 months once the brain
metastases were diagnosed, with a disease-specific mortal-
ity rate of 78%. A solitary lesion with complete surgical
resection was found to be associated with a better progno-
sis.
Misaki T et al [17] reported nine cases of differentiated
thyroid carcinoma that metastasized to the brain; seven of
them were PTC. They noticed that the median survival
time for patients after discovery of brain metastases is 9.4
Photomicrograph of the primary thyroid carcinoma illustrat- ing papillary carcinoma with tall cell features Figure 4
Photomicrograph of the primary thyroid carcinoma 
illustrating papillary carcinoma with tall cell features.
A thyroid transcriptional factor immunostaining of the brain  metastasis revealing strong nuclear staining in tumor cells Figure 5
A thyroid transcriptional factor immunostaining of 
the brain metastasis revealing strong nuclear staining 
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months. None of the brain lesions showed significant
uptake of radioactive iodine, probably due to the blood
brain barrier. It was recommended that CT scan or MRI
should be performed for any patient with suspicious neu-
rological symptoms. For therapy they recommended radi-
osurgery as alternative for surgical removal, although they
used it for only 2 patients.
Radioiodine scan may not be reliable to detect brain
metastasis from PTC [16,17]; however, a high serum thy-
roglobulin level may be helpful but not specific [16,17],
as it is usually high in all metastatic disease.
Surgery, radiotherapy, and radioactive iodine therapy
have been used with varying results for treatment of brain
metastases from papillary thyroid carcinoma. The best
therapeutic option seems to be resection, followed by
radioactive iodine therapy [4], although there is no clearly
defined protocol concerning the management of intracra-
nial metastases [4].
Retrospectively, the cause of the patient's hoarseness of
voice was the invasion of the recurrent laryngeal nerve by
the PTC. Approaching a patient with brain metastases
should involve the thyroid gland and the possibility of
brain metastases from PTC during the course of follow-up
should be kept in mind.
Conclusion
￿ Brain metastases secondary to PTC are rare and its
presentation before diagnosis of primary tumor is
only reported once, with our case. Due to its rarity,
insufficient data are present in its course, prognosis,
mortality, and management.
￿ There has been a general consensus in the literature
that brain metastases are associated with poor progno-
sis with tendency for recurrence, so close follow-up is
mandatory.
￿ Surgery is the treatment of choice for solitary resect-
able brain tumor, and radiotherapy should preserve
for patients with multiple lesions, or unresectable
tumors. Although this field still need more studies.
￿ Thyroid imaging can be helpful as a part of diagnos-
tic workup for patients with vocal cord paralysis and
brain metastasis.
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